v3.25.2
Financial Instrument
12 Months Ended
Mar. 31, 2025
Financial Instrument [Abstract]  
FINANCIAL INSTRUMENT

Note 8 — FINANCIAL INSTRUMENT

 

   As of March 31, 
   2024   2025   2025 
   S$   S$   US$ 
Financial instrument, beginning   221,791    231,293    172,029 
Net fair value change (Note 4)   9,502    5,478    4,074 
Financial instrument, ending   231,293    236,771    176,103 

 

On July 8, 2019, Rectitude Pte. Ltd., a wholly-owned subsidiary of the Company, entered into a life insurance policy (the “Policy”) with an insurance company to insure against death and terminal illness of a shareholder of the Company. Under the Policy, the beneficiary and policy holder is Rectitude Pte. Ltd. and the insured sum is US$1,000,000 for the shareholder. The Company can terminate the Policy on the occurrence of the earliest of the death of the shareholder insured or other terms pursuant to the contracts. The Company paid the total insurance premium of US$182,595 at the inception of the policy. The fair value is based on the redemption value quoted by the insurance company. There is no change in valuation approach and technique. The insurance policy is pledged to the bank as security for the Company’s bank loans (Note 12).

This Policy is recorded in the consolidated financial statements as “financial instrument”, represented by the total cash surrender value of the contract stated in the annual statement of the policy (Level 3). Changes in the cash value is recognized as “other income” in the consolidated statements of operations and comprehensive income.